Hope For Multiple Sclerosis: New Therapeutic Agent ST266 Shows Potential
As the efforts to eradicate the chronic condition caused by Multiple sclerosis continuously takes place after another, a new therapeutic agent has recently been tested in a mouse model of multiple sclerosis (MS). Consequently, the said experiment has been noted to have produced anti-inflammatory activity and prevented loss of cells in the optic nerve. It was found that the research has been conducted in the laboratory of Kenneth Shindler, MD, PhD, an associate professor of Ophthalmology and Neurology and the results have been published in the journal Scientific Reports.
New Therapeutic Agent Shows Potential As Multiple Sclerosis Cure
In one of their statements reported by News Medical Life Sciences, the researchers from the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics has allegedly discovered that there is a therapeutic potential of the agent, called ST266, for treating optic neuritis, inflammation that damages the optic nerve which is also a common presenting feature of MS. Furthermore, during their study, it turns out that nearly half of patients who were diagnosed with MS experience optic neuritis. The condition was also believed to have the ability to cause mild to moderate permanent loss of vision, but rarely complete blindness.
ST266 And Its Features
Meanwhile, as per News Wise, ST266 is known to be a solution of molecules that apparently stimulates paracrine signaling. It was found that through the said solution, it has become a means in which cells can communicate to each other: One cell is known to have the ability in producing a chemical signal that induces changes in nearby cells.
Ultimately, since the solution has been applied to mice, Shindler said that ST266's ability to preserve vision in the preclinical model and reduce neuronal loss would be a huge advance if it translates to human patients in the future. Additionally, the study findings suggest that ST266 helps promote optic neuron survival by potentially activating multiple pathways, including those that prevent cell death.
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
Recovery From Multiple Sclerosis Found In The So-Called 'tDCs' Technology, Details Inside
What is 'tDCs'? Considering that Multiple Sclerosis has been one of the world's fast emerging diseases, can the cure be found in this new technology called 'tDCs'? How can a patient recover from the aid auto-immune disease with the help of this technology? Here's what health professionals have to say
Apitope's Peptide Vaccine Finally Sheds Light To Multiple Sclerosis; Details Inside
With the continuous efforts to eradicate Multiple Sclerosis, how significant is Apitope's peptide vaccine for the said auto-immune disease? Could this vaccine be the advent of new medications to treat one of the diseases that has already affected millions of lives? Find out what experts have to say
New Stem Cell Treatment Finally Sheds Light To Multiple Sclerosis
As of the press time, a significant number of experts are still on the hunt to look for the best answer for Multiple Sclerosis. Now, what’s the truth behind a recent claim that a new stem cell treatment can allegedly ‘freeze’ the progression of the auto-immune disease? Could it finally be the answer to this long dreaded disease? Find out what experts have to say
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.